Alexithymia, anxiety and depression in patients with psoriasis: A case-control study

Annals of General Psychiatry

Volumn 13, Issue 1, 2014, Pages

  Korkoliakou, Panagiota ^a   Christodoulou, Christos ^a   Kouris, Anargyros ^a   Porichi, Evgenia ^a   Efstathiou, Vasiliki ^a   Kaloudi, Eythymia ^a   Kokkevi, Anna ^b   Stavrianeas, Nikolaos ^a   Papageorgiou, Charalabos ^a,b   Douzenis, Athanasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

Author keywords

Alexithymia; Anxiety; Depression; Psoriasis; TAS 20

Indexed keywords

ADULT; ALEXITHYMIA; ANXIETY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIFFICULTY IN DESCRIBING FEELING; DIFFICULTY IN IDENTIFYING FEELING; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTION; EXTERNALLY ORIENTED THINKING; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; THINKING; TORONTO ALEXITHYMIA SCALE;

EID: 84924157634     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/s12991-014-0038-7     Document Type: Article

References (26)

1. Sifneos PE: The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973, 22:255-262.
2. Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF, Tiago A, Camaioni D, Abeni D, Biondi M: Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J Psychosom Res 2003, 55:189-196.
3. Taylor GJ, Bagby RM, Parker JDA: Disorders of affect regulation: alexithymia in medical and psychiatric illness. Cambridge: Cambridge University Press; 1997.
4. Saarijärvi S, Salminen JK, Toikka TB: Alexithymia and depression: a 1-year follow-up study in outpatients with major depression. J Psychosom Res 2001, 51:729-733.
5. Bonnet A, Bréjard V, Pasquier A, Pedinielli JL: Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms. Affectivité et alexithymie 2012, 38:187-193.
6. Willemsen R, Roseeuw D, Vanderlinden J: Alexithymia and dermatology: the state of the art. Int J Dermatol 2008, 47:903-910.
7. Allegranti I, Gon T, Magaton-Rizzi G, Aguglia E: Prevalence of alexithymic characteristics in psoriatic patients. Acta Dermato-Venereologica, Suppl 1994, 186:146-147.
8. Swerlick RA, Lawley TJ: Eczema, psoriasis, cutaneous infection, acne and other common skin disorder. In Harrison's Principles of Internal Medicine. 14th edition. Edited by Fauci. New York: McGraw-Hill Inc; 1998:298-300.
9. Fortune DG, Richards HL, Main CJ, Griffiths CEM: What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998, 39:196-201.
10. Rubino IA, Sonnino A, Stefanato CM, Pezzarossa B, Ciani N: Separation-individuation, aggression and alexithymia in psoriasis. Acta Dermato-Venereologica Suppl 1989, 69:87-90.
11. Chaudhury S, Das AL, John RT, Ramadasan P: Psychological factors in psoriasis. Indian J Psychiatry 1998, 40:295-299.
12. Fava GA, Perini GI, Santonastaso P, Fornasa CV: Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980, 53:277-282.
13. Masmoudi J, Maalej I, Masmoudi A, Rached H, Rebai A, Turki H, Jaoua A: Alexithymia and psoriasis: a case-control study of 53 patients. Alexithymie et psoriasis 2009, 35:10-17.
14. Karanikas E, Harsoulis F, Giouzepas I, Griveas I, Chrisomallis F: Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters. J Dermatol 2009, 36:35-44.
15. Tsaousis I, Taylor G, Quilty L, Georgiades S, Stavrogiannopoulos M, Bagby RM: Validation of a Greek adaptation of the 20-item Toronto Alexithymia Scale. Compr Psychiatry 2010, 51:443-448.
16. Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, Fineti K, Patapis P, Protopapas K, Lykouras L: Hospital anxiety and depression scale (HADS): validation in a Greek general hospital sample. Ann Gen Psych 2008, 7:4.
17. Fredriksson T, Pettersson U: Severe psoriasis: oral therapy with a new steroid. Dermatologica 1978, 157:238-244.
18. Richards HL, Fortune DG, Griffiths CEM, Main CJ: Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res 2005, 58:89-96.
19. Rieder E, Tausk F: Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol 2012, 51:12-26.
20. Devrimci-Ozguven H, Kundakci N, Kumbasar H, Boyvat A: The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000, 14:267-271.
21. Richards HL, Fortune DG, Griffiths CEM, Main CJ: The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001, 50:11-15.
22. Honkalampi K, Koivumaa-Honkanen H, Lehto SM, Hintikka J, Haatainen K, Rissanen T, Viinamäki H: Is alexithymia a risk factor for major depression, personality disorder, or alcohol use disorders? A prospective population-based study. J Psychosom Res 2010, 68:269-273.
23. Motan I, Gençöz T: The relationship between the dimensions of alexithymia and the intensity of depression and anxiety. Turk Psikiyatri Derg 2007, 18(4):333-343.
24. Sayar K, Gulec H, Topbas M: Alexithymia and anger in patients with fibromyalgia. Clin Rheumatol 2004, 23:441-448.
25. Leweke F, Leichsenring F, Kruse J, Hermes S: Is alexithymia associated with specific mental disorders? Psychopathology 2012, 45:22-28.
26. Tolmunen T, Heliste M, Lehto SM, Hintikka J, Honkalampi K, Kauhanen J: Stability of alexithymia in the general population: an 11-year follow-up. Compr Psychiatry 2011, 52:536-541.